Wikidata

(Q40571024)

English

The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells.

scientific article published on April 2004

In more languages

Statements

title
The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15059883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15059883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40571024&oldid=2118011663"